Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Medshine Discovery Inc.”

61 pharma patents match "Medshine Discovery Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "Medshine Discovery Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “Medshine Discovery Inc.” · 30,257 patents in full index Clear search

  1. US 12421236

    Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

    Medshine Discovery Inc. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12351587

    Bicyclic compound as RIP-1 kinase inhibitor and application thereof

    Medshine Discovery Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  3. US 12351590

    Pyrrolopyrimidine compound and use thereof

    Medshine Discovery Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  4. US 12338218

    Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereof

    Medshine Discovery Inc. · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  5. US 12258367

    Glucoside derivative that acts as SGLT1 inhibitor and application thereof

    Medshine Discovery Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  6. US 12030897

    Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof

    Medshine Discovery Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  7. US 11905276

    Bicyclic compound that acts as CRBN protein regulator

    Medshine Discovery Inc. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  8. US 11814371

    Heterocyclic compound

    Medshine Discovery Inc. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  9. US 11718610

    Compounds containing benzosultam

    Medshine Discovery Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  10. US 11702400

    Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors

    Medshine Discovery Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  11. US 11691974

    3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors

    Medshine Discovery Inc. · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  12. US 11680070

    Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof

    Medshine Discovery Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  13. US 11673899

    Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor and use thereof

    Medshine Discovery Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  14. US 11655248

    Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor

    Medshine Discovery Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  15. US 11649239

    Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)

    Medshine Discovery Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  16. US 11639355

    Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

    Medshine Discovery Inc. · Granted May 2, 2023 · Expires Apr 27, 2043

    granted
  17. US 11634424

    Diazaindole derivative and use thereof as CHK1 inhibitor

    Medshine Discovery Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  18. US 11623923

    Uracil compound as c-MET/AXL inhibitor

    Medshine Discovery Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted
  19. US 11578081

    Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof

    Medshine Discovery Inc. · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  20. US 11572372

    Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds

    Medshine Discovery Inc. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  21. US 11465995

    Crystal and salt forms of tricyclic compound and preparation process thereof

    Medshine Discovery Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  22. US 11466024

    Bicylic compound acting as an inhibitor

    Medshine Discovery Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  23. US 11459323

    Monocyclic β-lactam compound for treating bacterial infection

    Medshine Discovery Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  24. US 11453667

    Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor

    Medshine Discovery Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted